6 results
medications sglt2 anthracycline cardiology cardiotoxicity chemotherapy comparison dosing dpp4 glftap her2 macroadenoma management masseffects mellitus mnemonic oncology renal sideeffects summary
SGLT2 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
- Pharmacology ... heart disease • All ... #Pharmacology # ... Summary #DM2 #diabetes ... #endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Sulfonylurea, TZD, DPP-4 inhibitor ... α-glucosidase inhibitor ... #Mellitus #DM2 ... #pharmacology # ... comparison #table #endocrinology
SGLT2 Inhibitors SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
class of anti-diabetic ... which causes the patient ... #Pharmacology # ... Medications #DM2 ... #Diabetes #Endocrinology
Pituitary Mass Effects - Pathogenesis and Clinical Findings • Pituitary turnors are almost always a benign
masses of all sizes ... Signs / Symptoms ... Hyperprolactinemia • Diabetes ... #SideEffects #endocrinology ... mnemonic #GLFTAP #pathophysiology
DPP4 Inhibitors - Normal and Renal Dosing Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
DPP4 Inhibitors ... If you see a patient ... Renal #Dosing #Pharmacology ... #Management #Diabetes ... #DM2 #Endocrinology
Management of Anthracyclines and HER2 Antagonist Cardiotoxicity Anthracyclines cause cardiomyopathy: ✖ Reduction in left ventricular ejection fraction
discussion with the patient ... system (RAAS) inhibitor ... hypertension, diabetes ... after 4 cycles for all ... cardiology #oncology #pharmacology
No results found for "acl pharmacology pathophysiology endocrinology signs pituitary diabetes inhibitors dm2 inpatient"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #acl #pharmacology #pathophysiology #endocrinology #signs #pituitary #diabetes #inhibitors #dm2 #inpatient